{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:04:52Z","timestamp":1775102692312,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8221\/A29017"],"award-info":[{"award-number":["C8221\/A29017"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C16077\/A29186"],"award-info":[{"award-number":["C16077\/A29186"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["10063259"],"award-info":[{"award-number":["10063259"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","award":["MSD2324_1620233"],"award-info":[{"award-number":["MSD2324_1620233"]}],"id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ebiom.2025.106117","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:30:06Z","timestamp":1767879006000},"page":"106117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation"],"prefix":"10.1016","volume":"124","author":[{"given":"Alison","family":"Dillman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haige","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4441-0015","authenticated-orcid":false,"given":"Zhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing Ching","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Blagden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Parsaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua R.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1932-7463","authenticated-orcid":false,"given":"Karl","family":"Smith-Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth C.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2025.106117_bib1","first-page":"326","article-title":"Global cancer burden growing, amidst mounting need for services","volume":"45","year":"2024"},{"issue":"18","key":"10.1016\/j.ebiom.2025.106117_bib2","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1002\/cam4.3345","article-title":"Insulin-like growth factor-1 and site-specific cancers: a Mendelian randomization study","volume":"9","author":"Larsson","year":"2020","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106117_bib3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/hmg\/ddaa026","article-title":"Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB","volume":"29","author":"Bicak","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib4","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1038\/s41467-024-48017-6","article-title":"Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank","volume":"15","author":"Papier","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","article-title":"Genetics meets proteomics: perspectives for large population-based studies","volume":"22","author":"Suhre","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ebiom.2025.106117_bib6","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6b","key":"10.1016\/j.ebiom.2025.106117_bib7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1079\/PHN2002394","article-title":"European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection","volume":"5","author":"Riboli","year":"2002","journal-title":"Public Health Nutrition"},{"key":"10.1016\/j.ebiom.2025.106117_bib8","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib9","first-page":"1","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","volume":"2","author":"Peterson","year":"2011","journal-title":"Ottawa: Ottawa Hospital Res Inst"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106117_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ebiom.2025.106117_bib11","series-title":"Large-Scale Randomized Evidence: Trials and Metaanalyses of Trials","first-page":"31","author":"Baigent","year":"2010"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106117_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106117_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ebiom.2025.106117_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Software"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B"},{"issue":"7726","key":"10.1016\/j.ebiom.2025.106117_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106117_bib18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41588-024-01894-5","article-title":"Rare coding variant analysis for human diseases across biobanks and ancestries","volume":"56","author":"Jurgens","year":"2024","journal-title":"Nature Genet"},{"key":"10.1016\/j.ebiom.2025.106117_bib19","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"issue":"6569","key":"10.1016\/j.ebiom.2025.106117_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj1541","article-title":"Mapping the proteo-genomic convergence of human diseases","volume":"374","author":"Pietzner","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106117_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.canep.2010.05.014","article-title":"Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?","volume":"34","author":"Gaudet","year":"2010","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106117_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41416-023-02541-2","article-title":"The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk","volume":"130","author":"Grassmann","year":"2024","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.ebiom.2025.106117_bib23","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1158\/0008-5472.CAN-20-3454","article-title":"Prospective identification of elevated circulating CDCP1 in patients years before onset of lung cancer","volume":"81","author":"Dagnino","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib24","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41467-023-37979-8","article-title":"The blood proteome of imminent lung cancer diagnosis","volume":"14","author":"Albanes","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106117_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/jnci\/djad071","article-title":"Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools","volume":"115","author":"Feng","year":"2023","journal-title":"JNCI (J Natl Cancer Inst)"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106117_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jnci\/djad122","article-title":"Circulating proteome for pulmonary nodule malignancy","volume":"115","author":"Khodayari Moez","year":"2023","journal-title":"JNCI (J Natl Cancer Inst)"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106117_bib27","article-title":"Circulating inflammation markers, risk of lung cancer, and utility for risk stratification","volume":"107","author":"Shiels","year":"2015","journal-title":"JNCI (J Natl Cancer Inst)"},{"issue":"24","key":"10.1016\/j.ebiom.2025.106117_bib28","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/jnci\/djt309","article-title":"Circulating inflammation markers and prospective risk for lung cancer","volume":"105","author":"Shiels","year":"2013","journal-title":"JNCI (J Natl Cancer Inst)"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106117_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/carcin\/bgx075","article-title":"A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai","volume":"38","author":"Shiels","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ebiom.2025.106117_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102288","article-title":"Pre-diagnostic circulating p53 autoantibodies and subsequent lung cancer risk in low-income African and European Americans","volume":"81","author":"Yoon","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106117_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/1055-9965.EPI-22-1113","article-title":"Associations between MICA and MICB genetic variants, protein levels, and colorectal cancer: Atherosclerosis Risk in Communities (ARIC)","volume":"32","author":"Wang","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106117_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1055-9965.EPI-17-0407","article-title":"Prediagnostic antibodies to serum p53 and subsequent colorectal cancer","volume":"27","author":"Teras","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12885-015-1058-7","article-title":"Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study","volume":"15","author":"Bertuzzi","year":"2015","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106117_bib34","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/ijc.31821","article-title":"Circulating inflammatory markers and colorectal cancer risk: a prospective case-cohort study in Japan","volume":"143","author":"Song","year":"2018","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib35","first-page":"5151","article-title":"A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk","volume":"11","author":"Harlid","year":"2021","journal-title":"Sci Re"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106117_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1158\/1940-6207.CAPR-22-0325","article-title":"Plasma concentrations of gut hormones acyl ghrelin and peptide YY and subsequent risk of colorectal cancer and molecular tumor subtypes","volume":"16","author":"Bod\u00e9n","year":"2023","journal-title":"Cancer Prev Res"},{"issue":"13","key":"10.1016\/j.ebiom.2025.106117_bib37","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.3390\/cancers14133261","article-title":"Prospective proteomic study identifies potential circulating protein biomarkers for colorectal cancer risk","volume":"14","author":"Sun","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106117_bib38","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/1055-9965.EPI-20-0780","article-title":"Auto-antibodies to p53 and the subsequent development of colorectal cancer in a U.S. prospective cohort consortium","volume":"29","author":"Butt","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1158\/1055-9965.EPI-13-0545","article-title":"Circulating soluble cytokine receptors and colorectal cancer risk","volume":"23","author":"Ho","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106117_bib40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/ijc.30797","article-title":"Hepcidin levels and gastric cancer risk in the EPIC-EurGast study","volume":"141","author":"Jakszyn","year":"2017","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106117_bib41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/1055-9965.EPI-18-1157","article-title":"Circulating inflammation markers and risk of gastric and esophageal cancers: a case\u2013cohort study within the Japan public health center\u2013based prospective study","volume":"28","author":"Camargo","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106117_bib42","first-page":"2245","article-title":"Circulating cytokines and gastric cancer risk","volume":"24","author":"Epplein","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106117_bib43","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1349-7006.2011.02033.x","article-title":"Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women","volume":"102","author":"Wong","year":"2011","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ijc.28337","article-title":"Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case\u2013control study","volume":"134","author":"Ohishi","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib45","article-title":"Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106117_bib46","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ijc.32763","article-title":"Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: a case\u2013cohort study in Japan","volume":"147","author":"Aversa","year":"2020","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106117_bib47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gutjnl-2018-316678","article-title":"Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium","volume":"68","author":"Cook","year":"2019","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106117_bib48","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/cvr\/cvab282","article-title":"Cardiovascular disease related circulating biomarkers and cancer incidence and mortality: is there an association?","volume":"118","author":"Jovani","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106117_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/cas.12485","article-title":"Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer","volume":"105","author":"Keeley","year":"2014","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","article-title":"Atlas of the plasma proteome in health and disease in 53,026 adults","volume":"188","author":"Deng","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I2 can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106117_bib52","article-title":"Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins","volume":"4","author":"Guida","year":"2018","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106117_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520959478","article-title":"CEACAM5 stimulates the progression of non-small-cell lung cancer by promoting cell proliferation and migration","volume":"48","author":"Zhang","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ebiom.2025.106117_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41420-022-01043-z","article-title":"Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway","volume":"8","author":"Di","year":"2022","journal-title":"Cell Death Discov"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106117_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12885-023-10523-z","article-title":"Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma","volume":"23","author":"Li","year":"2023","journal-title":"BMC cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cas.14257","article-title":"Integrin \u03b111 in non\u2013small cell lung cancer is associated with tumor progression and postoperative recurrence","volume":"111","author":"Ando","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ebiom.2025.106117_bib59","article-title":"Race\/ethnicity reporting and representation in US clinical trials: a cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106117_bib60","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s42003-024-06984-y","article-title":"Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels","volume":"7","author":"Iona","year":"2024","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106117_bib61","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","article-title":"Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies","volume":"54","author":"Zhang","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2025.106117_bib62","article-title":"Ancestry diversity in the genetic determinants of the human plasma proteome and associated new drug targets","author":"Said","year":"2023","journal-title":"medRxiv"},{"issue":"7982","key":"10.1016\/j.ebiom.2025.106117_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106117_bib64","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:46:37Z","timestamp":1775097997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":64,"alternative-id":["S2352396425005675"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106117","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106117"}}